(Q33906415)

29 July 2017

1 reference

title

The treatment of hyponatraemia using vasopressin antagonists (English)

1 reference

29 July 2017

0 references

Gross P

1

1 reference

29 July 2017

Palm C

series ordinal

2

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

published in

Experimental Physiology

1 reference

29 July 2017

volume

85 Spec No

1 reference

29 July 2017

page(s)

253S-257S

1 reference

Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Severe hyponatraemia in hospital inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Enhancement of vascular action of arginine vasopressin by diminished extracellular sodium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Neurogenic disorders of osmoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Cloning of the human type-2 vasopressin receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

Upregulation of aquaporin-2 water channel expression in chronic heart failure rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00030.X

10.1111/J.1469-445X.2000.TB00030.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference